Question-and-Answer Session
Operator
(Operator instructions). Your first question comes from the line of Derrick Sung with Sanford Bernstein.
Derrick Sung – Sanford Bernstein
Thanks for taking my question. If I could start on the hip and knee broad markets, it looks like the knee markets did pick up this quarter versus last quarter. I think our numbers have at least in the US growing at perhaps 6% versus 4%. And I was wondering if you could comment on whether what you are seeing is less deferral of procedures there or if you think we're actually starting to see moving of pent-up demand working through the system already.
David Dvorak
I think that when you reference the improvement, it looks to us to be of a point as opposed to two points within that U.S. market, Derrick. But I do think that you're just seeing stabilization. The economy broadly on variety of fronts begins to stabilize, people feel like they have more predictability in their futures and start to make decisions to move ahead, so, whether it's deferrals or a quicker turnaround of that individual it's come to the point where they need to have a replacement in either the knee or the hip category. They're moving forward with those procedures more rapidly I think. But again, this is a step. We have said all along that there was going to be no permanent solution. These were deferments. We weren't going to miss these procedures ultimately and so this is a step towards more normalized growth rate. You're really looking at kind of a point recovery of the three points to four points decline in procedure rates that we saw earlier in the year.
Derrick Sung – Sanford Bernstein
Okay. And if you could give us a status on the update of the regulatory filings for the new Acetabular Hip Cups that you have currently filed. Are you seeing any signs of any potential delays there or are those on track from your perspective?
David Dvorak
Well, those are 510K filings in the United States and so the filings have been made. As is usual we respond to questions as those filings progress through. And so that's the current status of it. I don't know that there's anything that looks all that unusual about those filings at this point in time, but of course, because of the 515 request that went out earlier in the year there's some potential that those filings could take on a different form or the requests that come from the FDA could take on a different form as well. So, there's no absolute assurances to timing on those clearances.
- To read the full transcript on Seeking Alpha, click here »
